STING unlocks CD4⁺ T cell immunity in pancreatic cancer
Cancer Cell · 2026-07 · 44 (7) · 1325-1326
DOI: 10.1016/j.ccell.2026.05.009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Cell, 2026-07. Verfasst von Bastian Kruse und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Immunology, Institute of Immunology, Eberhard Karls University of Tübingen, Tübingen, Germany; M3 Research Center, Univers…. Hauptthemen laut MEDLINE: CD4-Positive T-Lymphocytes, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal, Membrane Proteins. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Pancreatic ductal adenocarcinomas (PDACs) are lethal cancers resistant to immunotherapies. In this issue of Cancer Cell, Kureshi et al. show that combining checkpoint blockade with STING-mediated innate immune stimulation unlocks cDC2-driven CD4+ T cell immunity in mice, promoting PDAC immune control. This cellular axis may be exploited for PDAC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Experimental Immunology, Institute of Immunology, Eberhard Karls University of Tübingen, Tübingen, Germany; M3 Research Center, University Hospital Tübingen, Eberhard Karls University of Tübingen, Tübingen…
Zitieren
APA
Kruse, B., Leonhardt, B. P., & Böttcher, J. P. (2026). STING unlocks CD4⁺ T cell immunity in pancreatic cancer. Cancer Cell, 44(7), 1325-1326. https://doi.org/10.1016/j.ccell.2026.05.009
Vancouver
Kruse B, Leonhardt BP, Böttcher JP. STING unlocks CD4⁺ T cell immunity in pancreatic cancer. Cancer Cell. 2026;44(7):1325-1326. doi:10.1016/j.ccell.2026.05.009
BibTeX
@article{Kruse2026,
author = {Kruse, Bastian and Leonhardt, Ben P and Böttcher, Jan P},
title = {STING unlocks CD4⁺ T cell immunity in pancreatic cancer},
journal = {Cancer Cell},
year = {2026},
volume = {44},
number = {7},
pages = {1325--1326},
doi = {10.1016/j.ccell.2026.05.009}
}
EUVIMED